NCT00760396View on ClinicalTrials.gov

Multiple-Dose Study of VGX-1027 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

April 30, 2009

Conditions
Healthy
Interventions
DRUG

VGX-1027

Subjects will

Trial Locations (1)

21201

SNBL Clinical Pharmacology Center, Inc., Baltimore

Sponsors
All Listed Sponsors
collaborator

GeneOne Life Science, Inc.

INDUSTRY

lead

VGX Pharmaceuticals, LLC

INDUSTRY

NCT00760396 - Multiple-Dose Study of VGX-1027 in Healthy Subjects | Biotech Hunter | Biotech Hunter